About Us

We provide specialist services to the pharmaceutical industry

We are a flexible organisation, with resources and infrastructure to handle projects of all sizes.

Founded in 2008, S-cubed UK provides clients with a wide range of tailored services, from in-sourcing solutions, individual ad-hoc advice and consultancy, to delivering large projects.

Our team of over 30 carefully selected and highly experienced staff has extensive expertise in supporting projects ranging from pre-clinical and clinical development, pharmaceutical licensing in the EU and US, medical technology research and other healthcare management activities.

Recognising that one size doesn’t fit all, we customise our services to meet client needs. We focus on providing a high level of expertise and cost-effective solutions.

We have long lasting relationships with our clients. Our vision is that every client will experience complete confidence in the knowledge, abilities and reliability of our staff, and will see clear benefits and results from our involvement in their projects.

Based in the UK, we work with clients from around the globe.

You can read all Our Stories from our fantastic staff here.

Management

Mark Lipscombe

Managing Director, S-cubed Ltd

Prior to co-founding S-cubed Ltd in 2008, Mark had worked in the pharmaceutical industry for 10 years, most recently as a Principal Consultant with PA Consulting Group’s Life Sciences and Healthcare Practice, based in London. During his time as a consultant, Mark has worked with a wide variety of groups including pharmaceutical, biotechnology and investment companies. Prior to entering consultancy, Mark spent 6 years working in the drug development industry as a Clinical Project Manager.

Stephen Thompson

Director of Regulatory Affairs

Stephen joined S-cubed Ltd in early 2009, bringing over ten years’ regulatory affairs experience, most recently as a Director in the Regulatory Affairs group at Constella Group (formerly Origin Pharmaceutical Services). Stephen has provided regulatory support to a number of pharmaceutical and biotechnology companies and has worked with most European regulatory agencies and the US FDA. He has a proven track-record of successfully supporting products through development to registration and subsequent license maintenance. Stephen holds a PhD in Chemistry.

Nicola Wright

Director of Regulatory Affairs

Upon joining S-cubed Ltd in November 2011, Nicola brought strong leadership and comprehensive registration and regulatory expertise to the regulatory affairs team, acquired through more than eighteen years of experience within the pharmaceutical industry. Nicola provides a strong insight into the differing commercial pressures of product development, gained from working with a wide variety of organisations, ranging from large multinational organisations to small generics companies. Nicola holds an MSc in Biochemical Engineering.

Mark Baillet

Managing Director & Consultant Statistician

Prior to starting S-cubed Biometrics Ltd in 2011, Mark was Vice President, Data Sciences at SRA Global Clinical Development, where he successfully formed, grew and led the global Biometrics department. Mark has over 23 years’ experience in conducting, managing and leading statistics, programming and data management functions within small and large pharmaceutical and biotech companies, including positions at Pfizer and British Biotech. Mark is a chartered statistician with expertise in statistical consultancy, biometrics project management, statistical programming, drug development and commercial business strategy.

Mark Lipscombe

Managing Director, S-cubed Ltd

Prior to co-founding S-cubed Ltd in 2008, Mark had worked in the pharmaceutical industry in various drug development roles as a Clinical Project Manager before joining with PA Consulting Group’s Life Sciences and Healthcare Practice, based in London, as a Principal Consultant. During his time as a consultant, Mark has worked with a wide variety of groups including pharmaceutical, biotechnology and investment companies. Mark has more than 25 years of experience in the life sciences industry and holds a Master’s in Business Administration.

Stephen Thompson

Director of Regulatory Affairs

Stephen joined S-cubed Ltd in early 2009, following his role as a Director in the Regulatory Affairs group at Constella Group (formerly Origin Pharmaceutical Services). With over 25 years’ experience in Regulatory Affairs, Stephen provides high level regulatory expertise to a wide range pharmaceutical and biotechnology companies and has worked with most European regulatory agencies and the US FDA. He has a proven track-record of successfully supporting products through development to registration and beyond. Stephen has particularly strong expertise in supporting client companies with regulatory strategic development alongside his significant experience in licensing of medicinal products. Stephen holds a PhD in Chemistry.

Nicola Wright

Director of Regulatory Affairs

Upon joining S-cubed Ltd in November 2011, Nicola brought strong leadership and comprehensive regulatory expertise to the S-cubed team. Nicola has over 30 years’ experience within the pharmaceutical industry and regulatory consultancy environments. With this length of service she brings significant breadth of knowledge in regulatory affairs, complemented by a strong insight into the differing commercial pressures of product development through to marketing, gained from working with a wide variety of organisations, ranging from large multinational organisations to small, virtual companies. Nicola holds an MSc Eng in Biochemical Engineering.

Mark Baillet

Managing Director & Consultant Statistician

Prior to co-founding S-cubed Biometrics Ltd in 2011, Mark was Vice President, Data Sciences at SRA Global Clinical Development, where he successfully formed, grew and led the global Biometrics CRO department. Mark has over 35 years’ experience in conducting, managing and leading statistics, programming and data management functions within small and large pharmaceutical and biotech companies and CROs, including positions at Pfizer and British Biotech. Mark is a chartered statistician with expertise in statistical consultancy, statistical programming, drug development and commercial business strategy.